These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 11268479

  • 1. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M, Medrano MJ, Gutierrez A, López A, Mugüerza JM, Hernández P, Lozano O, Noguerales F, Ruíz A, Granell J.
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [Abstract] [Full Text] [Related]

  • 2. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC.
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [Abstract] [Full Text] [Related]

  • 3. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I, Maehara Y, Koga T, Sumiyoshi Y, Oshiro T, Baba H, Kohnoe S, Okamura T, Uike N, Matsusaka T, Kume K, Sugimachi K.
    Hepatogastroenterology; 2003 Oct; 50(51):877-82. PubMed ID: 12828109
    [Abstract] [Full Text] [Related]

  • 4. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M, Medrano M, Mugüerza JM, Ramos P, Hernandez P, Villeta R, Martín A, Noguerales F, Ruiz A, Granell J.
    Anticancer Res; 2000 Oct; 20(5C):3907-12. PubMed ID: 11268475
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK.
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC.
    J Surg Oncol; 2007 May 01; 95(6):461-8. PubMed ID: 17192913
    [Abstract] [Full Text] [Related]

  • 7. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3412-8. PubMed ID: 17909917
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
    Inada T, Kawakubo H, Ichikawa A, Ogata Y.
    Gan To Kagaku Ryoho; 1999 Feb 01; 26(3):315-20. PubMed ID: 10065094
    [Abstract] [Full Text] [Related]

  • 9. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
    Yonemura Y, Kinoshita K, Fujimura T, Fushida S, Sawa T, Matsuki N, Tanaka S, Kamata T, Takashima T, Miyazaki I.
    Hepatogastroenterology; 1996 Feb 01; 43(11):1260-72. PubMed ID: 8908561
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M, Italian Oncology Group for Cancer Research, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.
    J Natl Cancer Inst; 2008 Mar 19; 100(6):388-98. PubMed ID: 18334706
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
    Potrc S, Gadiijev E, Hajdinjak T, Kavalar R.
    Hepatogastroenterology; 2007 Mar 19; 54(73):308-14. PubMed ID: 17419281
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 13. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
    Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1488-94. PubMed ID: 18538489
    [Abstract] [Full Text] [Related]

  • 14. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE, Almasri NM, Khader YS, Sheyab FM, Karam HN.
    Clin Cancer Res; 2005 Feb 15; 11(4):1447-53. PubMed ID: 15746045
    [Abstract] [Full Text] [Related]

  • 15. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP, Yu HJ, Lee JH.
    Hepatogastroenterology; 2001 Feb 15; 48(41):1227-30. PubMed ID: 11677936
    [Abstract] [Full Text] [Related]

  • 16. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ, Sun XW, Li W, Chen YB, Xu L, Guan YX, Li YF, Xu DZ.
    Ai Zheng; 2005 May 15; 24(5):596-9. PubMed ID: 15890105
    [Abstract] [Full Text] [Related]

  • 17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 15; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 18. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
    Grau JJ, Martín M, Fuster J, Pera M, García-Valdecasas JC, Bombí JA, Bordas JM, Alcobendas F, Grande L, Estapé J.
    J Surg Oncol; 2003 Apr 15; 82(4):234-40. PubMed ID: 12672007
    [Abstract] [Full Text] [Related]

  • 19. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M.
    J Surg Oncol; 2007 Feb 01; 95(2):123-8. PubMed ID: 17262742
    [Abstract] [Full Text] [Related]

  • 20. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K, Mochizuki Y, Machida T, Yokoyama S, Sodeyama H, Sode Y, Wakabayashi M, Kawamura N, Miyazaki T.
    Hepatogastroenterology; 1999 Feb 01; 46(26):1238-43. PubMed ID: 10370699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.